Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Endocrine gland neoplasm"'
Publikováno v:
Annals of Medicine and Surgery
Introduction and importance The differential diagnosis of a paediatric abdominal mass can be extensive, as it potentially involves multiple organs including gastrointestinal, genitourinary, endocrine, and gynaecological systems. Hence, a systematic a
Autor:
Raksha Bhat, Hariprasad Thangavel, Noor Mazin Abdulkareem, Suhas Vasaikar, Carmine De Angelis, Leon Bae, Maria Letizia Cataldo, Sarmistha Nanda, Xiaoyong Fu, Bing Zhang, Rachel Schiff, Meghana V. Trivedi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
G Protein-Coupled Receptors (GPCRs) represent the largest superfamily of cell-surface proteins. However, the expression and function of majority of GPCRs remain unexplored in breast cancer (BC). We interrogated the expression and phosphorylation stat
Publikováno v:
Cirugía y Cirujanos. 89
Undescended parathyroid adenoma is a rare cause of primary hyperparathyroidism that happens < 1% of cases. If not suspected, it can lead to a negative bilateral parathyroid exploration and extensive iatrogenic trauma. We propose that with proper imag
Publikováno v:
Indian Journal of Pathology and Oncology. 6:190-198
Introduction: Although endocrine cancers are relatively uncommon, they represent an important group of potentially treatable cancers. Materials and Methods: This clinicomorphological study on endocrine neoplasms excluding thyroid had total of 26 case
Autor:
Rishabh Gupta
Publikováno v:
Journal of Surgical Case Reports
Multiple endocrine neoplasia type 2A (MEN2A) is a hereditary syndrome associated with tumours of the endocrine system. Principally, it is characterized by medullary thyroid carcinoma (MTC) with some individuals also developing phaeochromocytoma and h
Autor:
Giulia Puliani, Pasqualino Malandrino, Antongiulio Faggiano, Annamaria Anita Livia Colao, Elia Guadagno, Barbara Altieri, Tiziana Feola, Andrea M. Isidori, Concetta Sciammarella, Elisa Giannetta, Valentina Guarnotta
An increased calcitonin serum level is suggestive of a medullary thyroid cancer (MTC), but is not pathognomonic. The possibility of false positives or other calcitonin-secreting neuroendocrine neoplasms (NENs) should be considered. Serum calcitonin l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2e0071bbf7242eb7ca7d9ef6cb8e62
http://hdl.handle.net/10447/540637
http://hdl.handle.net/10447/540637
Autor:
Giannetta E., Guarnotta V., Altieri B., Sciammarella C., Guadagno E., Malandrino P., Puliani G., Feola T., Isidori A. M., Colao A. A. L., Faggiano A.
An increased calcitonin serum level is suggestive of a medullary thyroid cancer (MTC), but is not pathognomonic. The possibility of false positives or other calcitonin-secreting neuroendocrine neoplasms (NENs) should be considered. Serum calcitonin l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::96deda6e36149881a2391a4f4537af2f
http://hdl.handle.net/11588/857683
http://hdl.handle.net/11588/857683
Autor:
Nirupa Sachithanandan, Richard Norris, Elisa Bongetti, David A. Pattison, Rodney J. Hicks, Melissa H Lee, Richard J MacIsaac
Publikováno v:
Clinical Case Reports
Key Clinical Message Despite growing evidence for GLP‐1R molecular‐based imaging, successful localization of insulinomas may require the use of multiple imaging modalities. Not all benign insulinomas express the GLP‐1R as expected. Our case dem
Autor:
Henriett Butz, Fabio Rotondo, William D. Foulkes, John R. Priest, Michael D. Cusimano, Michael Solarski, Kalman Kovacs, Luis V. Syro
Publikováno v:
Endocrine-Related Cancer. 25:R197-R208
In this review, the importance of theDICER1gene in the function of endocrine cells is discussed. There is conclusive evidence thatDICER1mutations play a crucial role in the development, progression, cell proliferation, therapeutic responsiveness and
Publikováno v:
Annales de Pathologie. 37:444-456
The WHO classification of the tumors of endocrine organs, published in July 2017, has introduced significant changes in the classification of pancreatic neuroendocrine tumors, the previous version of which has appeared in 2010, within the WHO classif